Gonal-f RFF Redi-ject is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Emd Serono, Inc.. The primary component is Follitropin.
| Product ID | 44087-1115_2e6b585c-986b-4838-a7fa-326b34b5c146 |
| NDC | 44087-1115 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Gonal-f RFF Redi-ject |
| Generic Name | Follitropin |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2013-10-16 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021684 |
| Labeler Name | EMD Serono, Inc. |
| Substance Name | FOLLITROPIN |
| Active Ingredient Strength | 300 [iU]/.5mL |
| Pharm Classes | Gonadotropin [EPC],Gonadotropins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2013-10-16 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA021684 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2013-10-16 |
| Marketing Category | BLA |
| Application Number | BLA021684 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2013-10-16 |
| Marketing End Date | 2014-08-25 |
| Ingredient | Strength |
|---|---|
| FOLLITROPIN | 300 [iU]/.5mL |
| SPL SET ID: | b6d11c45-b502-478e-bb28-2ff596ea259c |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 44087-1115 | Gonal-f RFF Redi-ject | FOLLITROPIN |
| 44087-1116 | Gonal-f RFF Redi-ject | FOLLITROPIN |
| 44087-1117 | Gonal-f RFF Redi-ject | FOLLITROPIN |
| 44087-1118 | Gonal-f RFF Redi-ject | FOLLITROPIN |
| 0052-0313 | Follistim AQ | follitropin |
| 0052-0316 | Follistim AQ | follitropin |
| 0052-0326 | Follistim AQ | follitropin |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() GONAL-F RFF REDI-JECT 86110018 4689651 Live/Registered |
Merck KGaA 2013-11-04 |